Your browser doesn't support javascript.
loading
Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
Lin, Ying-Li; Wang, Yun-Peng; Li, Hong-Zhao; Zhang, Xu.
Afiliação
  • Lin YL; Department of Urology, Chinese PLA General Hospital/Chinese PLA Medical School, Beijing, China (mainland).
  • Wang YP; Department of Urology, Xuzhou Cancer Hospital, Affiliated Xuzhou Hospital of Jiangsu University, Xuzhou, Jiangsu, China (mainland).
  • Li HZ; Department of Urology, Chinese PLA General Hospital/Chinese PLA Medical School, Beijing, China (mainland).
  • Zhang X; Department of Urology, Chinese PLA General Hospital/Chinese PLA Medical School, Beijing, China (mainland).
Med Sci Monit ; 23: 3318-3323, 2017 Jul 08.
Article em En | MEDLINE | ID: mdl-28688232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Caderinas / Regiões Promotoras Genéticas / Metilação de DNA / Neoplasias Renais Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Caderinas / Regiões Promotoras Genéticas / Metilação de DNA / Neoplasias Renais Idioma: En Ano de publicação: 2017 Tipo de documento: Article